|
|
|
|
| Stage at admission to BC: IVA, persistent | BC. October 7, 2011 PB, gemcitabine |
|
| Regional radiology CT January 5, 2012 | SD | 431 | 228 | Non- conclusive (tissue- Caris) |
| 12 | Regional hospital February 1, 2010 | APMD | Regional radiology CT January 2010 | Mass in the pancreatic head | Stent placement January 18, 2010, Whipple procedure February 1, 2010 |
|
|
|
|
|
|
|
|
|
|
|
| Lung, lymph node, and mesenteric metastases | Clinical trial gemcitabine plus vaccination | Regional radiology CT May 13, 2011 | Recurrence |
|
|
|
|
|
|
|
|
|
|
| RT August 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
| RT and capecitabine to September 2011 | Regional radiology PET/CT November 2, 2011 | Recurrence |
|
|
|
|
|
|
|
|
|
| Stage at admission to BC: IVB, recurrent | BC. November 4, 2011 PB, nab-paclitaxel x5 gemcitabine x1 |
|
| Regional radiology PET/CT January 25, 2012 | SD | 872 | 231 | Negative (blood and tissue- Caris) |
| 13 | Regional hospital September 27, 2011 | APMD | Regional radiology CT September 25, 2011 | Mass in the pancreatic head | Stent placement September 25, 2011, FOLFIRINOX x3 October 9, 2011-November 20, 2011 |
|
|
|
|
|
|
|
|
|
|
|
| Liver and peritoneal metastases |
| Regional radiology CT December 13, 2011 | Recurrence |
|
|
|
|
|
|
|
|
|
|
| Stent placement |
|
|
|
|
|
|
|
|
|
|
|
|
| Capecitabine December 11, 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| Gemcitabine and docetaxel, capecitabine January 2, 2012-January 18, 2012 | Regional radiology CT March 4, 2012 | Recurrence |
|
|
|
|
|
|
|
|
|
| Stage at admission to BC: IVB, recurrent | BC. February 29, 2012 PB, pazopanib- discontinued (financial concerns, duration-1 day). Everolimus- discontinued (duration-2 days), erlotinib, gemcitabine, nab-paclitaxel |
|
| Regional radiology CT July 3, 2012 | PD | 304 | 148 | Negative (blood), RRM1, SPARC, Poly- clonal- Negative Monoclonal above the threshold (tissue- Caris) |